Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...
Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...
Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...
CANBERRA, Oct 10 (Reuters) - Australia's Queensland state government said on Friday it would run coal power plants at least into the 2040s, reversing a previous plan to pivot rapidly to renewables and ...
Scientists at EPFL have reimagined 3D printing by turning simple hydrogels into tough metals and ceramics. Their process allows multiple infusions of metal salts that form dense, high-strength ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback